Explore more topics
SEC Form 4 research

Horizon Therapeutics Public Ltd Co insider transactions

Inspect Horizon Therapeutics Public Ltd Co's public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001492426
Reporting owners
62
Officers and directors
30
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 33 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

SHERMAN JEFFREY W000123048226
GREY MICHAEL G000124012273
Daniel William F00015294092
Clayton Sean M.00019119981
Himawan Jeff0001342821200
Cox Aaron00019243511
SANTINI GINO00012760382
FORMELA JEAN FRANCOIS000103057592
Thompson Elizabeth H.Z.00018614779
Camardo Daniel A.00018203657
Carey Robert000160206439
ADATTO MICHAEL00015233862
Beeler Brian K000164158017
BIRD JEFFREY W0001250409121
Birner Hubert000139859835
BOCK LOUIS C0001279735129
CURTIS GEOFFREY M.000166790310
DE VAERE ROBERT J00012401163
DesJardin Michael A.000151298514
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP000136799829
Hoelscher Paul W.000161146818
Johann Peter000136994211
Karnani Vikram00016994889
Kent Jeff00017691079
Konstantinovsky Irina000171605911
McHugh Miles W00013662278
MOZE BARRY000161950019
Nohria Virinder00016190772
Pasternak Andy000179274620
Shannon James Samuel00014854176
SMITH TODD N00015236724
Walbert Timothy P000134937686
Watkins Thomas000130793518

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.